This inventor holds 2 USPTO granted patents. Top assignee: University of Illinois. Active years: 2006-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2014
Title: Chengjian Mao: Innovator in Hormonal Research
Introduction
Chengjian Mao is a prominent inventor based in Savoy, IL (US). He has made significant contributions to the field of hormonal research, particularly in the development of compositions and methods related to nuclear hormone and steroid hormone receptors. With a total of 2 patents, his work has the potential to impact cancer treatment and gene therapy.
Latest Patents
Chengjian Mao's latest patents include groundbreaking research on compositions and methods relating to nuclear hormone and steroid hormone receptors. One of his notable patents focuses on inhibitors of estrogen receptor alpha-mediated gene expression and the inhibition of breast cancer. This patent discusses the use of compounds, such as substituted theophyllines, that can function as inhibitors of estrogen receptor alpha-mediated gene expression. These compounds have the ability to modify cancer cells and treat various forms of cancer, including breast cancers that are resistant to tamoxifen.
Another significant patent involves a tamoxifen-inducible and ICI 182,780-repressible expression system. This system comprises mutant estrogen receptors and mutant estrogen response elements, which have a wide range of applications in gene therapy and both in vivo and in vitro expression. The innovative nature of these patents showcases Chengjian Mao's commitment to advancing medical science.
Career Highlights
Chengjian Mao is affiliated with the University of Illinois, where he conducts his research and development. His work has garnered attention for its potential applications in treating hormone-related cancers and improving gene therapy techniques. His innovative approaches have positioned him as a key figure in the field of hormonal research.
Collaborations
Chengjian Mao has collaborated with notable colleagues, including David J. Shapiro and Milu Tresa Cherian. These collaborations have further enriched his research and contributed to the advancement of their shared goals in the field.
Conclusion
Chengjian Mao is a distinguished inventor whose work in hormonal research has the potential to revolutionize cancer treatment and gene therapy. His innovative patents and collaborations reflect his dedication to improving medical science and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
